Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION The …
{{id}} {{{paragraph}}}
Example: dental hygienist
HIGHLIGHTS OF PRESCRIBING INFORMATION The …
HIGHLIGHTS OF PRESCRIBING INFORMATION These HIGHLIGHTS do not include all the INFORMATION needed to use RITUXAN safely and effectively. See full PRESCRIBING INFORMATION for RITUXAN. RITUXAN (rituximab) injection, for intravenous use Initial Approval: 1997 WARNING: FATAL INFUSION REACTIONS, SEVERE MUCOCUTANEOUS REACTIONS, HEPATITIS B VIRUS REACTIVATION and PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY See full PRESCRIBING INFORMATION for complete boxed warning. Fatal infusion reactions within 24 hours of RITUXAN infusion; approximately 80% of fatal reactions occurred with first infusion.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RITUXAN safely and effectively. See full prescribing information for
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: